Overview of Carbosylane

Property	Description
Active ingredients	Activated Charcoal, Simethicone
Form	Oral Capsule (Hard Capsule)
Pharmacological class	Gastrointestinal Therapeutic Agent (Adsorbent and Antiflatulence)
Common use	Relief from issues related to excessive intestinal gas and bloating
Origin	Combination of natural-derived (Charcoal) and synthetic (Simethicone) substances

What is Carbosylane and What Type of Medicine is it?

Carbosylane is a specific, non-systemic gastrointestinal therapeutic agent delivered as an oral capsule, classified as an Antiflatulent/Intestinal Adsorbent. This is a fixed-dose combination product designed to address physical issues within the digestive system. The synergistic rationale for co-formulating these agents combines distinct mechanical actions in one specialty preparation. The drug is engineered to exert its full effect locally within the gut lumen following oral administration, minimizing systemic exposure.

Composition: Activated Charcoal, Simethicone, and Unique Features

The core of Carbosylane is its dual composition, pairing the intestinal adsorbent Activated Charcoal with the antifoaming agent Simethicone [INN]. Simethicone acts by reducing surface tension, which is a mechanical process for breaking down gas bubbles in the gut. This action assists in dissolving frothy foam and gas pockets.

The formulation features a specialized dual capsule design, often consisting of a gastro-soluble capsule and a gastro-resistant capsule, which allows for the release of the two active ingredients sequentially in different parts of the digestive system. This specialized form differentiates Carbosylane from standard single-release formulations by providing targeted delivery.

What is the General Purpose of Carbosylane?

The general purpose of this combination medicine is to provide fundamental symptomatic relief by physically managing the presence of excessive gas and associated substances within the gastrointestinal tract. Activated Charcoal and Simethicone are agents used for managing common issues related to intestinal gas, such as the feeling of fullness or pressure. By facilitating the removal or passage of trapped gas and related material, the drug helps re-establish a more comfortable physical state within the digestive system.

Regulatory References

What side effects are possible with Carbosylane?

Possible Side Effects and Safety Information

The safety profile for Carbosylane, as documented in official regulatory sources, defines adverse reactions and mandatory restrictions for use.

Documented Adverse Reactions

The most frequently documented adverse events relate to the digestive system. However, specific frequencies (e.g., 'common' or 'rare') cannot be estimated from available data, and these events are classified as having an indeterminate frequency.

System-Organ Classes Involved

System Class	Reported Effects
Gastrointestinal Disorders	Constipation, diarrhea, abdominal discomfort, pain, vomiting
Immune System Disorders	Allergic reactions (including anaphylactic-like reactions)
Skin and Subcutaneous Tissue Disorders	Hives (urticaria), rash

Safety Restrictions and Limitations

Official regulatory documents stipulate specific restrictions and safety considerations essential for the medicine's use.

Contraindications: The medicine must not be used in individuals with known hypersensitivity (allergy) to the active substances or any of the excipients. It is also contraindicated in children under 6 years old due to a specific risk of choking.
Drug Interactions: Due to the medicine’s adsorbing properties, it must be taken separately from other medications (ideally by more than 2 hours) to avoid reducing the absorption and effectiveness of other treatments.
Dose-Related Pattern: The use of high dose levels is explicitly documented to cause a dark discoloration of the stools.
Use in Specific Populations: While use during breastfeeding may be permitted, use during pregnancy requires medical advice before initiation.

Overdose and Emergency Response

Overdose and When to Seek Help

This information reflects the official overdose profile documented in government regulatory sources, such as the Summary of Product Characteristics (SmPC) and patient information leaflets.

Documented Overdose Manifestations

Official regulatory documents indicate that the primary, non-serious manifestation of Carbosylane overdose is related to the activated charcoal component:

Dark colouration of the stools

This manifestation results from the use of high dose levels of the product.

Emergency Actions and Urgent Help

Regulatory agencies consistently advise that medical attention should be sought immediately if an overdose occurs. The product labeling does not specify any severe or life-threatening systemic outcomes resulting from overdosage that would trigger unique emergency measures.

Required Action: Contact your doctor or pharmacist immediately.
Antidote Information: No specific antidote is listed in the official regulatory documentation for Carbosylane overdose.

Overdose Profile Summary

The documented profile for Carbosylane overdose is characterized by a low risk of systemic toxicity, with clinical effects being limited to the expected, non-serious gastrointestinal change noted above. Regulatory guidance focuses on immediate contact with a healthcare professional following overexposure, without detailing specialized supportive or monitoring requirements in the official overdose section.

Therapeutic Uses of Carbosylane

Carbosylane is commonly used to help with the symptomatic relief of physical discomfort and difficult digestion. The therapeutic application of this medication is intended for easing symptoms related to intestinal gas and physical tension. It is applicable across domains where additional symptomatic support is needed and is relevant in contexts marked by increased abdominal discomfort.

It is generally used to address key symptomatic domains, including meteorism, flatulence, and symptoms of dyspepsia such as post-meal heaviness. The medication is often used during phases when symptoms become more noticeable, providing supportive relief that assists with maintaining functional stability. It contributes to easing the overall symptom load, which is especially relevant for conditions characterized by periods of heightened symptoms.

“This medication is primarily used to address symptom clusters that interfere with daily functioning, supporting general well-being during symptomatic periods.”

The medication may also be part of symptomatic management in specific clinical contexts, such as situations requiring short-term symptomatic assistance relevant in contexts involving heightened systemic burden.

Quick Fact: Addresses Abdominal Fullness and Pressure

Regulatory References

Health Canada Labelling Standard for Antiflatulents

Eligibility and Restrictions for Use

Carbosylane's eligibility profile is strictly defined by government regulatory documents, outlining populations permitted to use the medicine and those who are formally contraindicated. The medicine must not be used by any individual with a known allergy or hypersensitivity to the active ingredients, Activated Charcoal or Simethicone, or to any component of the capsule formulation. The product is also contraindicated for all children under the age of six years. This restriction is explicitly tied to the physical form of the medicine, which presents an official risk of choking or inhalation in this young age group.

The medicine is permitted for use in adults, older adults, and children aged six years and older, provided no other contraindications exist. For reproductive health, official labeling places restrictions on use during pregnancy. Use should not be envisaged unless necessary and requires consultation with a healthcare professional. This conditional status is due to a lack of complete epidemiological data to confirm the absence of risk, despite the non-systemic action of the active ingredients. Conversely, use during lactation (breastfeeding) is generally permitted according to the official documentation. Furthermore, regulatory documents do not specify eligibility restrictions based on pre-existing hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Carbosylane is primarily defined by the Activated Charcoal component, which acts as a non-specific intestinal adsorbent. This leads to a documented pharmacokinetic interaction that alters the systemic exposure of other co-administered oral medicines.

Official Interaction Restrictions and Outcomes

Category	Documented Regulatory Statement
Interacting Substances	All other oral medicines are subject to this interaction [National Drug Regulatory Leaflets].
Pharmacokinetic Outcome	Co-administration may reduce the uptake (absorption) and resulting systemic exposure of the co-administered oral drug, potentially leading to decreased efficacy [MHRA, National Drug Leaflets].
Timing-Based Restriction	A mandatory administration timing separation is required: other oral medicines must be taken at an interval of more than 2 hours from Carbosylane [National Drug Regulatory Leaflets].

Substance Interaction Cautions

Official cautions advise that the same potential for reduced absorption may apply to other ingested substances. Users are advised to avoid alcohol consumption and use caution when taking herbal products or nutritional supplements due to the risk of reduced bioavailability. No specific drug-drug combinations are formally listed as contraindicated due to this interaction mechanism, and the components are not known to engage in systemic CYP-mediated or transporter-mediated interactions.

Mechanism of Action

️ How Carbosylane Works

Modulation of Intraluminal Surface Tension

This mechanism is driven by Simethicone, an inert silicone polymer that functions as a surfactant strictly within the gastrointestinal (GI) lumen. By reducing the surface tension of the liquid-gas interface in the gut, the agent destabilizes the persistent foam structure (froth) that traps gas. This action converts numerous small, stable gas bubbles into fewer, larger bubbles , which ultimately facilitates their natural physiological expulsion and reduces the physical pressure exerted on the intestinal walls.

High-Capacity Physical Adsorption

This separate action is performed by Activated Charcoal, which possesses an exceptionally large and porous surface area. It utilizes physical forces (adsorption kinetics) to bind and immobilize gas molecules, metabolic byproducts, and unwanted substances onto its surface. This process prevents the molecules from being absorbed or interacting with the intestinal lining, ensuring they are rendered inert and excreted with the stool, contributing to the net reduction of the intraluminal gas load.

Complementary Dual-Action Synergy

The coordinated function of the combination relies on the complementary sequencing of actions. Simethicone's surfactant action first physically disrupts the foam, thereby making the trapped materials more accessible to the Charcoal's surface. This synergy results in coordinated physical control of both the state (foam disruption) and the volume (molecular load) of the gas within the digestive tract.

Dosage and Administration Information

Official Instructions for Administration

Carbosylane is exclusively administered via the oral route. The medication's usage is structured around a specialized dosing protocol involving two separate capsules. A single dose unit consists of one blue gastro-soluble capsule and one red gastro-resistant capsule taken simultaneously. This dual-capsule system is designed to ensure sequential release of the active ingredients in both the stomach and the intestine.

The standard adult regimen requires the administration of this dose unit three times a day (T.I.D.). To ensure proper administration, both the red and blue capsules must be swallowed whole with a small amount of water; they are not to be chewed. Doses are typically timed in relation to food intake, administered before and/or after main meals.

A critical procedural constraint is necessary when combining Carbosylane with other treatments. Due to the action of the activated charcoal component, all other oral medicines must be taken at least one hour before or one hour after Carbosylane to prevent reduced absorption of the co-administered drug.

Regarding duration, the use of Carbosylane should not extend beyond 10 days without consulting a health professional. The standard adult dosing regimen is applicable to older adults, but the capsules are generally not indicated for children under the age of 6 due to the associated risk of choking.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Combination of Activated Charcoal and Simethicone

Research explored whether the combination of Activated Charcoal and Simethicone was associated with changes in acute symptoms related to gas and dyspepsia (difficult digestion). The research involved several randomized controlled trials (RCTs) and systematic reviews.

Studies were conducted to examine the combination's effects, which involve the two ingredients acting on intestinal gas. Activated charcoal is known for its adsorbing properties, while Simethicone is a substance that modifies the surface tension of gas bubbles.

Key Efficacy and Safety Studies

One randomized prospective study examined the effects of the activated charcoal-simethicone combination in patients consulting a general practitioner for dyspeptic syndrome. The study found that a 3-month course of the combination was associated with significant symptomatic change compared to placebo. Secondary data indicated that differences in symptoms such as abdominal fullness, bloating, and sensation of slow digestion were noted after 90 days.

The safety profile examined in the studies indicated that the combination was generally well-tolerated. Reported events were typically mild and related to the gastrointestinal system.

Monotherapy and Other Comparisons

One meta-analysis comparing the combination with other agents, such as Simethicone monotherapy and water, was used to evaluate its use in preparation for upper gastrointestinal endoscopy. Findings from this analysis were used to examine mucosal visibility scores among the groups.

Research Gaps

Studies did not widely examine the combination’s effects in pediatric populations or in patients with certain co-morbidities. Further investigation is needed to explore these specific populations.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Carbosylane (FAQ)

Q: Is Carbosylane safe to use during pregnancy or while breastfeeding?

According to official product information, use during pregnancy requires consultation with a healthcare professional and should only be considered if essential. Conversely, use during lactation (breastfeeding) is described as permitted according to the official documentation.

Q: Does Carbosylane affect the absorption of nutrients from food?

The activated charcoal component of Carbosylane is known to adsorb substances in the gastrointestinal tract, primarily affecting the absorption of other oral medicines. Regulatory cautions advise that this potential for reduced uptake may also apply to other ingested substances, including nutritional supplements.

Q: Does Carbosylane affect bowel movement frequency?

Official documentation lists both constipation and diarrhea as possible adverse effects related to the digestive system. However, specific frequency for these events cannot be estimated from the currently available data.

Q: Is it normal to notice changes in stool color while using Carbosylane?

Yes, regulatory documents explicitly state that the use of high dose levels is documented to cause a dark discoloration or brownish color of the stools. This is related to the presence of the activated charcoal component.

Q: Is it necessary to space out Carbosylane from other medications?

A mandatory timing separation is required between Carbosylane and all other oral medicines due to the action of activated charcoal. This is because the charcoal may reduce the uptake and effectiveness of other co-administered oral drugs. It is necessary that the separation time of at least one hour before or one hour after taking Carbosylane be respected.

Q: Can Carbosylane be taken with food, or should it be taken on an empty stomach?

According to the official product information for administration, doses of Carbosylane are typically timed in relation to food intake. They are generally administered before and/or after main meals.

Q: What is the typical duration of treatment with Carbosylane?

The standard adult treatment duration should not extend beyond 10 days without consulting a health professional. Official documentation restricts the maximum duration of use, noting that it is intended for short-term symptomatic use.

Q: What is the main difference between Carbosylane and other similar over-the-counter options?

Carbosylane is described as a fixed-dose combination product containing both Activated Charcoal and Simethicone. Its specialized feature is a two-capsule system—one gastro-soluble and one gastro-resistant—designed for the sequential release of the ingredients in different parts of the digestive system.

Q: Is Carbosylane the same thing as activated charcoal?

No, Carbosylane is a combination product that contains two active ingredients. It pairs the intestinal adsorbent Activated Charcoal with the antifoaming agent Simethicone.

Q: Can Carbosylane be used long-term, or is it only for short-term use?

Official documentation indicates that the use of Carbosylane is generally restricted to a maximum of 10 days without seeking medical advice. This signals that the medicine is intended for short-term use to manage acute symptoms.

Q: Does Carbosylane cause constipation or diarrhea?

Official documents list both constipation and diarrhea as reported gastrointestinal adverse effects associated with the use of the medicine.

Q: Can Carbosylane interact with my daily vitamins or supplements?

Official cautions advise users to exercise caution when taking nutritional supplements or herbal products. The charcoal component acts as a non-specific adsorbent, which means it may reduce the bioavailability of co-administered oral substances, requiring the mandated time separation.

Q: Are there any documented cases of serious allergic reactions to Carbosylane?

Official documentation lists Allergic reactions as a possible adverse effect, including reactions described as anaphylactic-like reactions. The medicine is formally contraindicated in individuals with a known hypersensitivity (allergy) to the active substances or excipients.

Q: What happens if I miss taking Carbosylane at the recommended time?

Patient information leaflets specifically instruct patients not to take a double dose to make up for a forgotten dose.

Q: Does Carbosylane contain lactose or gluten?

The excipients (non-medicinal ingredients) listed in the Summary of Product Characteristics for this formulation do not include lactose or gluten.

Q: Is Carbosylane known to affect birth control pills?

The activated charcoal component may reduce the absorption and effectiveness of all other oral medicines, which includes oral contraceptives. Therefore, it is necessary to respect the mandatory time separation between Carbosylane and other oral medications.

Q: Why do some people refer to Carbosylane as an 'antiflatulent'?

Carbosylane is officially classified by the World Health Organization (WHO) as an Antiflatulent/Intestinal Adsorbent. The medicine's therapeutic indication is listed as an anti-flatulent because it is used for the physical management of excessive intestinal gas.

Q: Can Carbosylane be crushed or opened if a person has trouble swallowing?

No. Official instructions for administration state that both the red and blue capsules must be swallowed whole with a small amount of water. Official instructions state that the specialized dual-capsule system should not be altered.

Q: Are there any known interactions between Carbosylane and alcohol?

Official cautions advise users to avoid alcohol consumption. The activated charcoal component may reduce the bioavailability of alcohol, similar to its effect on other ingested substances.

Q: Are there any restrictions on driving or operating machinery while using Carbosylane?

Official regulatory documents state that the product has no or negligible influence on the ability to drive and use machines.

Q: Does Carbosylane have an expiration date?

Yes, the packaging includes an expiry date (EXP). Official instructions state that the medicine should not be used after the date indicated on the packaging.

Q: What should I do if my symptoms do not improve after using Carbosylane?

Official documents advise that if symptoms persist or worsen, or if constipation is prolonged, the patient is advised to seek medical advice.

Q: Can Carbosylane be taken with other gastrointestinal medicines?

Yes, but they must be taken at an interval of at least one hour before or one hour after Carbosylane. The activated charcoal component may reduce the absorption and effectiveness of other oral medicines, including other gastrointestinal treatments.

Q: Are there specific instructions for storing Carbosylane?

Official documents state that no special precautions for storage are required, indicating stability at standard ambient temperatures. However, the medicine must be kept out of the sight and reach of children and not used past the expiry date.

Q: Is it okay to take Carbosylane with pain relievers like paracetamol or ibuprofen?

The activated charcoal component may reduce the absorption and effectiveness of all other oral medicines, which includes pain relievers. The mandated separation time of at least one hour before or after taking Carbosylane should be respected to manage the risk of reduced absorption.

How should Carbosylane be stored and disposed of?

How to Store and Dispose of Carbosylane?

Carbosylane (activated charcoal/simethicone) has a storage profile that requires no special precautions for storage, indicating stability at standard ambient temperatures. The primary requirements focus on protection and time constraints.

Storage and Handling

Requirement	Official Statement
Temperature Requirements	No special precautions for storage are required.
Child Safety	Keep this medicine out of the sight and reach of children.
Shelf Life	Do not use this medicine after the expiry date (EXP) stated on the packaging.

Disposal Instructions

Official regulations prohibit the disposal of this medicine through waste-water or household wastes. To ensure proper environmental protection, patients must ask a pharmacist how to dispose of any medicine that is no longer required.

Carbosylane